Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $1.65 Million - $1.87 Million
-15,500 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $1.25 Million - $1.68 Million
15,500 New
15,500 $1.66 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tt International Asset Management LTD Portfolio

Follow Tt International Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tt International Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tt International Asset Management LTD with notifications on news.